|
Clinical utility of a liquid biopsy diagnostic approach in lung cancer using amplicon-based next-generation sequencing in parallel with allele-specific PCR. |
|
|
No Relationships to Disclose |
|
|
Employment - Lucence Diagnostics |
Patents, Royalties, Other Intellectual Property - Drug delivery technology, diagnostics technology |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
|
|
No Relationships to Disclose |
|
|
Employment - Lucence Diagnostics |
|
|
Employment - Lucence Diagnostics |
Leadership - Lucence Diagnostics |
Stock and Other Ownership Interests - Lucence Diagnostics |
Patents, Royalties, Other Intellectual Property - Drug delivery technology, diagnostics technology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Lucence Diagnostics |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |